Larimar Therapeutics, Inc. (LRMR)

NGM – Real vaqt narxi. Valyuta: USD

4.32

+0.01 (0.35%)

Bozor ochiq: Aug 12, 2026, 2:07 PM EDT

4.30

-0.01 (-0.23%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

04.08.2026

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update

BALA CYNWYD, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today reported its second quarter 2026 operating and financial results.

Videolar

No Data

There is no data to display

Press-relizlar

04.08.2026

Larimar Therapeutics, Inc. (LRMR)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Larimar Therapeutics, Inc. (LRMR)

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update

Videolar

No Data

Press-relizlar

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update

Videolar

No Data

Press-relizlar

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update

Search stocks

Larimar Therapeutics, Inc. (LRMR)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Larimar Therapeutics, Inc. (LRMR)

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update

Videolar

No Data

Press-relizlar

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update

Videolar

No Data

Press-relizlar

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update